Although the mean aminotransferase levels in lean NAFLD fall within the normal range, NAFLD patients in both lean and overweight cohorts exhibited elevated levels of ALT and AST, as well as AKP, γ-GT and CHE compared to their healthy counterparts. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.